Omniscan (Gadodiamide)

Gadodiamide, the active ingredient in Omniscan, is a contrast media presented as a 0.5 ml/mL solution for intravenous use. It enhances magnetic resonance imaging (MRI) scans to improve visualization of vascular structures and tissue characteristics. GNH USA supplies Omniscan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Omniscan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Omniscan is used as an MRI contrast agent to improve diagnostic imaging of several body systems.

- Central nervous system imaging: enhances detection of lesions, tumors and vascular abnormalities. - Cardiovascular imaging: improves visualization of cardiac chambers, vessels and perfusion defects. - Abdominal and pelvic imaging: clarifies organ structure and lesion delineation in liver, kidneys and reproductive organs.

Adverse reactions to Omniscan may vary from mild to severe and are monitored during and after administration.

Common Side Effects: - Nausea: mild, transient feeling of stomach upset. - Headache: brief, self‑limiting discomfort. - Injection site pain: mild soreness at the infusion site. - Warm sensation: fleeting feeling of warmth or flushing. - Dizziness: short‑term light‑headedness. - Metallic taste: temporary alteration in taste perception.

Serious or Rare Side Effects: - Nephrogenic systemic fibrosis (NSF): fibrotic skin changes in patients with severe renal impairment. - Anaphylactic reaction: severe allergic response requiring immediate medical intervention. - Severe hypotension: sudden drop in blood pressure. - Cardiac arrest: rare but life‑threatening event. - Pulmonary edema: fluid accumulation in the lungs. - Acute kidney injury: rapid decline in renal function.

When using Omniscan, clinicians should assess patient history and monitor for adverse events.

- Renal function assessment: evaluate glomerular filtration rate before administration. - Allergy history: verify no prior severe reactions to gadolinium agents. - Hydration status: ensure adequate patient hydration to facilitate renal clearance. - Pregnancy considerations: use only if clearly needed, weighing fetal risk. - Pediatric use: adjust dosing based on weight and monitor closely. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Omniscan may interact with other agents that affect renal function or trigger hypersensitivity.

Major Interactions (Avoid): - Loop diuretics: may exacerbate renal impairment when combined. - High‑dose intravenous iron: can increase risk of hypersensitivity.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may reduce renal clearance. - Metformin: monitor for lactic acidosis in patients with declining renal function. - ACE inhibitors or ARBs: watch for additive effects on kidney function. - Calcium channel blockers: may potentiate hypotensive responses. - Radiopharmaceuticals: coordinate timing to avoid overlapping contrast exposure.